Concordance of ultrasound dual imaging and ultrasound endoscopy in re-staging of progressive gastric cancer after neoadjuvant therap
返回论文页
|更新时间:2023-10-11
|
Concordance of ultrasound dual imaging and ultrasound endoscopy in re-staging of progressive gastric cancer after neoadjuvant therap
Journal of Clinical Ultrasound in MedicineVol. 24, Issue 3, (2022)
作者机构:
重庆市急救医疗中心 重庆市第四人民医院
作者简介:
基金信息:
DOI:
CLC:
Published:2022,
Published Online:2 April 2022,
扫 描 看 全 文
Concordance of ultrasound dual imaging and ultrasound endoscopy in re-staging of progressive gastric cancer after neoadjuvant therap. [J]. Journal of Clinical Ultrasound in Medicine 24(3).(2022)
DOI:
Concordance of ultrasound dual imaging and ultrasound endoscopy in re-staging of progressive gastric cancer after neoadjuvant therap. [J]. Journal of Clinical Ultrasound in Medicine 24(3).(2022)DOI:
Concordance of ultrasound dual imaging and ultrasound endoscopy in re-staging of progressive gastric cancer after neoadjuvant therap
【Abstract】 Objective: To investigate the concordance between ultrasound dual imaging and ultrasound endoscopy in the re-staging of progressive gastric cancer (AGC) after neoadjuvant therapy. Methods: Retrospective analysis of medical records of 63 patients with AGC treated in our hospital from January 2018 to January 2020
who underwent dual ultrasound tracing and ultrasound endoscopy after neoadjuvant therapy
and analysis of the T-stage
lesion size and surrounding tissue invasion of patients after neoadjuvant therapy by these two examination modalities. Results: Among 63 patients with AGC
dual ultrasonography diagnosis showed 12 cases of T2 stage
34 cases of T3 stage and 17 cases of T4 stage
while ultrasound endoscopy diagnosis showed 11 cases of T2 stage
32 cases of T3 stage and 20 cases of T4 stage. The agreement rate between dual ultrasonography and ultrasound endoscopy for the diagnosis of T-stage after neoadjuvant therapy was 84.13% with strong agreement (Kappa=0.738). There was no statistically significant difference in the value of double ultrasonography versus ultrasound endoscopy for the assessment of right and left
longitudinal and anterior and posterior diameters of lesions after neoadjuvant treatment (P > 0.05). The diagnostic agreement between dual ultrasonography and ultrasound endoscopy on whether the transverse colon and its mesentery were invaded after neoadjuvant treatment was 79.37% and moderate (Kappa=0.471). The agreement rate between dual ultrasonography and ultrasound endoscopy for the diagnosis of liver and spleen invasion after neoadjuvant therapy was 71.43% with moderate agreement (Kappa=0.581). The concordance rate between dual ultrasonography and ultrasound endoscopy for the diagnosis of duodenal and pancreatic invasion after neoadjuvant therapy was 73.02% with moderate concordance (Kappa=0.613). Conclusion:Ultrasound dual contrast and endoscopy after AGC neoadjuvant treatment have a high consistency in T staging and lesion size
but the consistency in the assessment of tissue invasion is moderate.